Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-10-11FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ENTACAPONE submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2013-07-31FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for Bromocriptine Mesylate, resulting in updated labeling for the product.
-
FDA approval · 2013-07-31FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited. This action updates the p…
-
FDA approval · 2013-05-13FDA Approved: TRIHEXYPHENIDYL HYDROCHLORIDE — Supplemental Application (Akorn)
FDA approved a supplemental application for Akorn's Trihexyphenidyl hydrochloride.
-
FDA approval · 2013-05-11FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for TASMAR (tolcapone) submitted by Bausch Health US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-30FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for TASMAR (tolcapone) filed by Bausch Health US LLC.
-
FDA approval · 2013-04-22FDA Approved: ROPINIROLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for a generic ropinirole product.
-
FDA approval · 2013-04-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Sun Pharmaceutical's carbidopa-levodopa, updating the regulatory approval for this product.
-
FDA approval · 2013-04-05FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for the carbidopa/levodopa/entacapone combination from Sandoz Inc, representing an approved regu…
-
FDA approval · 2013-04-03FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sun Pharmaceutical Industries’ generic Carbidopa and Levodopa under an ANDA.
-
FDA approval · 2013-03-14FDA Approved: CYCLOSET — Supplemental Application (Avvisto Therapeutics LLC)
FDA approved a supplemental application for CYCLOSET (bromocriptine mesylate) from Avvisto Therapeutics LLC.
-
FDA approval · 2013-02-08FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's generic carbidopa and levodopa combination under an Original Application, providing a generic option for Pa…
-
FDA approval · 2013-02-05FDA Approved: BENZTROPINE MESYLATE — Original Application (Navinta LLC)
FDA approved Navinta LLC's original application for benztropine mesylate, a generic anticholinergic drug indicated for Parkinsonism and drug…
-
FDA approval · 2012-11-28FDA Approved: BENZTROPINE MESYLATE — Original Application (Leading Pharma, LLC)
FDA approved the original ANDA for benztropine mesylate from Leading Pharma, LLC, making a generic version available. It is indicated for th…
-
FDA approval · 2012-11-28FDA Approved: ROPINIROLE — Original Application (Bionpharma Inc.)
FDA approved the original application for ropinirole from Bionpharma Inc., representing a generic version of ropinirole. This marks the avai…
-
FDA approval · 2012-10-31FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Torrent Pharmaceuticals Limited.
-
FDA approval · 2012-10-26FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Pramipexole dihydrochloride as a generic product, manufactured by Aurobindo Pharma Limited, for th…
-
FDA approval · 2012-09-20FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited, marking the entry of a generic …
-
FDA approval · 2012-08-13FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for bromocriptine mesylate (ANDA 078899) submitted by Zydus Pharmaceuticals USA Inc., granting regul…
-
FDA approval · 2012-06-06FDA Approved: ROPINIROLE — Original Application (Dr. Reddys Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's generic ropinirole tablets via an original ANDA. Ropinirole is used to treat Parkinson's dis…
-
FDA approval · 2012-06-05FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for amantadine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2012-05-17FDA Approved: ROPINIROLE — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s original application for ropinirole, a generic formulation used to treat Parkinson's disease and res…
-
FDA approval · 2012-05-14FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic carbidopa-levodopa product manufactured by Mylan Pharmaceuticals.
-
FDA approval · 2012-04-02FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) from UCB, Inc.
-
FDA approval · 2012-02-23FDA Approved: ROPINIROLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for ropinirole from Glenmark Pharmaceuticals Inc., USA.